Patents Assigned to University of Cincinnati
  • Patent number: 6416869
    Abstract: A method of treating a metal substrate by applying a coating of a silane composition having at least one substantially unhydrolyzed aminosilane having one or more secondary or tertiary groups. Methods of adhering a polymer (such as rubber) to a metal substrate are also provided.
    Type: Grant
    Filed: July 19, 1999
    Date of Patent: July 9, 2002
    Assignee: University of Cincinnati
    Inventors: Wim J. van Ooij, Senthil K. Jayaseelan, Eric A. Mee
  • Patent number: 6409874
    Abstract: Adhesion of rubber to a variety of metals (aluminum, stainless steel, mild steel and brass) is effectively achieved by the application of an organofunctional silane (I) and a non-organofunctional silane (II) to the requisite surface. Preferably, the organofunctional silane (I) is a vinyltrialkoxysilane with the non-organofunctional silane (II) preferably comprising an alkoxylated substituted alkyl silane. The silanes (I) and (II) are at least partially hydrolyzed and are normally provided in the form of a EtOH/H2O solution. Bonded joints formed by these adhesive treatments can withstand fuel degradation tests indicating that the treatments can be used, for example, to bond metal and rubber surfaces in automotive and other environments in which the joined parts will be contacted by fuels, oil and/or organic solvents.
    Type: Grant
    Filed: June 19, 2000
    Date of Patent: June 25, 2002
    Assignees: Vernay Laboratories, Inc., University of Cincinnati
    Inventors: Cornelis P. J. Van Der Aar, Wim J. Van Ooij
  • Patent number: 6409760
    Abstract: A static device for use with the heart that has a plurality of members configured to be positioned adjacent the epicardial surface of the heart. The members are joined by at least one connector wherein the members are fixed in a spatial or spaced relationship relative to each other such that a portion of the heart wall is displaced inwardly. The member(s) can be configured in a rectangular shape, and preferably includes an inner surface having a curved configuration. In one embodiment, the device can have first and second member that are positioned in a spaced relationship relative to each other about 180 degrees apart. The first member is configured to be positioned adjacent the anterolateral surface of the chamber, and the second member configured to be positioned adjacent the posteromedial surface of the chamber.
    Type: Grant
    Filed: June 21, 2000
    Date of Patent: June 25, 2002
    Assignee: University of Cincinnati
    Inventor: David B. Melvin
  • Patent number: 6406930
    Abstract: A visible light emitting device includes a wide band gap semiconductor layer doped with one or more elements which emit light at various wavelengths based upon atomic transitions. The semiconductor preferably is GaN, InN, AIN, BN or alloys thereof doped with a lanthanide element such as Er, Pr or Tm. The light emission can be enhanced by annealing the WBGS.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: June 18, 2002
    Assignee: University of Cincinnati
    Inventors: Ronald H. Birkhahn, Liang-Chiun Chao, Michael J. Garter, James D. Scofield, Andrew J. Steckl
  • Patent number: 6387956
    Abstract: A method of treating an obsessive-compulsive spectrum disorder comprises the step of administering an effective amount of tramadol to an individual.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: May 14, 2002
    Assignee: University of Cincinnati
    Inventors: Nathan A. Shapira, Toby D. Goldsmith, Paul E. Keck, Jr.
  • Patent number: 6372296
    Abstract: The present invention relates to galvanized steel having a high aluminum content in the coating, as well as a batch hot-dip galvanization process for making such steel. The galvanized steel herein has a coating comprising an inner layer of intermetallic iron aluminum compounds, such as Fe2Al5 (which may have some zinc present), and an outer layer of intermetallic zinc aluminum compounds containing from about 17% to about 40% (preferably about 22%, the Zn—Al eutectoid) aluminum (which may have some iron present). The batch hot-dip galvanization process for making such steel comprises: (a) fluxing the steel by electroless plating on the surface of the steel of a metal such as tin, copper or nickel; and (b) dipping the fluxed steel into a molten galvanization bath comprising zinc and from about 17% to about 40% aluminum.
    Type: Grant
    Filed: May 21, 1999
    Date of Patent: April 16, 2002
    Assignee: University of Cincinnati
    Inventors: Wim J. van Ooij, Prasanna Vijayan
  • Patent number: 6365411
    Abstract: In the rain forest region of Karnataka State, India, a scandent herb Justicia known as “medicine plant” is widely consumed by the local population by incorporating its extract into desserts. This is especially common in the months of June through August because of the belief that the medicinal properties reach their peak during this season. This plant is now considered to be distributed exclusively in this region of the South Indian rain forest. The plant extract lowers cellular cholesterol and cholesteryl ester concentration. Further studies also showed a novel inhibitory effect on the uptake of ox-LDL by human macrophage cell line.
    Type: Grant
    Filed: June 7, 2000
    Date of Patent: April 2, 2002
    Assignee: University of Cincinnati
    Inventors: M. T. Ravi Subbiah, Eric J. Norman
  • Patent number: 6365698
    Abstract: Grafted-polysilanes with a greater efficiency for the photoinitiation of vinyl type resins are provided. These grafted polysilanes which include both grafted cyclic polysilanes and grafted networked polysilanes have variable composition and length molecular chains grafted onto the silane backbone which aid in the solubility in vinyl type resins.
    Type: Grant
    Filed: October 16, 1998
    Date of Patent: April 2, 2002
    Assignees: Three Bond Co., Ltd., University of Cincinnati
    Inventors: Barry Goldslager, Stephen J. Clarson
  • Patent number: 6365185
    Abstract: The present invention relates to tablets which are time-controlled to release active agent at different rates in different regions of the digestive tract in order to maintain a substantially constant concentration in the blood. In one embodiment, a new modified release drug delivery system, for once a day peroral use, consisting of a solid core comprising an active agent together with a hydrogel, with the solid core being coated with a semi-permeable, self-destructing membrane which is optionally drilled to provide a release orifice, and then optionally further coated with the same or different active agent material. The device delivers the active agent in a substantially constant effective dose for the duration of the transit through the stomach and small intestine, followed by accelerated release when reaching the large intestine.
    Type: Grant
    Filed: March 26, 1999
    Date of Patent: April 2, 2002
    Assignee: University of Cincinnati
    Inventors: Wolfgang A. Ritschel, Mukul A. Agrawal
  • Patent number: 6362471
    Abstract: The hazards of exposure to heavy metal contamination, examples of which arsenic, beryllium, lead, cadmium, chromium, nickel, zinc, mercury and barium, and the radioactive substances which deposit in human bone, examples of which are uranium, plutonium, and americium, are very serious and are well known to scientific and medical professionals. Since lead is a prevalent metal contaminant which deposits in human bone, and its effects are quite hazardous, especially to young children, the focus of this disclosure will be on methods of detecting lead exposure. While it is possible to detect the level of lead in the body through the use of a blood test, the relevancy of such tests is limited, since the risk to humans from lead exposure is related to the amount of lead deposited in the bones of the exposed person and not, necessarily, the amount in the blood.
    Type: Grant
    Filed: May 14, 1999
    Date of Patent: March 26, 2002
    Assignee: University of Cincinnati
    Inventors: Henry B. Spitz, Mark Jenkins, Robert Bornschein, Jeffrey Lodwick
  • Patent number: 6344121
    Abstract: The methods of the present invention address a critical need for the development of preparative chiral separations. These include preparative chiral separation methods based on continuous electrophoresis using a chiral additive in the buffer. The application of continuous free flow electrophoresis to bulk scale aqueous chiral separations is novel and has the potential for obtaining mg to g/hour quantities of both pure enantiomers of chiral drugs in aqueous solution, with wide applicability for a broad range of chiral drugs from many different categories as well as chiral intermediates or metabolites. The present methods allow for the potential recovery and reuse of the chiral selector (typically expensive and/or rare). Although continuous free flow electrophoresis has been used primarily for the separation of biopolymers, its use for the separation of small molecules has remained relatively unexplored.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: February 5, 2002
    Assignee: University of Cincinnati
    Inventors: Apryll Marie Stalcup, Richard Matthew Charles Sutton
  • Patent number: 6335169
    Abstract: Eukaryotic cells have evolved a mechanism that delays the onset of anaphase until chromosomes are properly positioned on the spindle. To understand the molecular basis of such surveillance mechanism in human cells, we have cloned a full-length cDNA encoding a putative mitotic checkpoint kinase termed hBub1. Sequence comparison reveals that hBub1 is a structurally conserved protein, sharing 23% amino acid residue identity with BUB1 of budding yeast. In addition, the N-terminal portion (161 amino acids) of hBub1 shows a significant homology to yeast MAD3, a protein also known to be involved in the mitotic checkpoint response pathway. Northern blot analyses show that hBub1 mRNA level is abundantly expressed in tissues or cells with a high mitotic index. When Dami cells undergoes terminal differentiation following treatment with phorbol ester, hBub1 expression in this cell line is rapidly downregulated. The hBub1 protein level is low in G1 and remains relatively constant in S, G2 and M phases.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: January 1, 2002
    Assignee: University of Cincinnati
    Inventors: Wei Dai, Bin Ouyang, Huiqi Pan, Zhengdao Lan
  • Patent number: 6323236
    Abstract: Impulse Control Disorders (ICD's) are characterized by harmful behaviors performed in response to irresistible impulses. The essential feature of an ICD is the failure to resist an impulse, drive, or temptation and to perform an act that is harmful to the person or to others. The present invention comprises methods for the treatment or prevention of ICD's using a class of sulfamates of the following formula: wherein X is CH2 or oxygen, and R1, R2, R3, R4 and R5 are as herein defined. Further, pharmaceutical compositions containing a compound of formula (I) as well as methods for their use and intermediates form part of the present invention are also disclosed.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: November 27, 2001
    Assignee: University of Cincinnati
    Inventor: Susan McElroy
  • Publication number: 20010015469
    Abstract: A visible light emitting device includes a wide band gap semiconductor layer doped with one or more elements which emit light at various wavelengths based upon atomic transitions. The semiconductor preferably is GaN, InN, AIN, BN or alloys thereof doped with a lanthanide element such as Er, Pr or Tm. The light emission can be enhanced by annealing the WBGS.
    Type: Application
    Filed: April 30, 2001
    Publication date: August 23, 2001
    Applicant: University of Cincinnati
    Inventors: Ronald H. Birkhahn, Liang-Chiun Chao, Michael J. Garter, James D. Scofield, Andrew J. Steckl
  • Patent number: 6277874
    Abstract: Methods for treating diseases associated with toxicity of Apolipoprotein E (“apoE”). Specifically, the present invention relates to new methods for treating a mammal having a condition associated with toxicity of apolipoprotein E cleavage fragments containing residues 130-169, comprising administering to said mammal a pharmacologically effective amount of compound or a pharmaceutically acceptable sale, derivative or fragment thereof to interfere with the receptor-binding site associated with residues 130-169 of the apolipoprotein E molecule in said mammal.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: August 21, 2001
    Assignee: University of Cincinnati and Apologic, Incorporated
    Inventors: Keith A. Crutcher, Judith A. K. Harmony
  • Patent number: 6261638
    Abstract: A method of treating a metal substrate by applying a first coating treatment solution of 0.1% by volume of at least one silane, wherein the silane consists only of a multi-functional silane having at least two trisubstituted silyl groups, wherein the substituents are individually chosen from the group consisting of alkoxy and acetoxy, and wherein the multi-functional silane has been at least partially hydrolyzed and wherein the first coating treatment solution has a pH of less than about 7.
    Type: Grant
    Filed: November 1, 1999
    Date of Patent: July 17, 2001
    Assignee: University of Cincinnati
    Inventors: Wim J. van Ooij, Vijay Subramanian, Chunbin Zhang
  • Patent number: 6258263
    Abstract: A chromatograph fabricated using microelectromechanical techniques. The chromatograph includes a first layer superimposed over a second layer. At least one micro-channel is etched into the second layer to provide the separation column of the chromatograph. The surfaces of the micro-channel are chemically activated in order to separate the components of a sample flowing through the micro-channel by bonded phase chemistry. A third layer is placed in superimposed relationship with the second layer. At least one pair of electrodes is formed to the third layer with at least a portion of the electrodes internal to the micro-channel of the second layer. The electrodes detect separated components flowing through the micro-channel and identify them by their electrical conductivity. The depth of the micro-channel is greater than the width, thereby minimizing pressure drop across the device and allowing the chromatograph to operate with a high degree of speed, sensitivity and accuracy.
    Type: Grant
    Filed: September 17, 1999
    Date of Patent: July 10, 2001
    Assignee: The University of Cincinnati
    Inventors: H. Thurman Henderson, Neville R. deGouvea-Pinto
  • Patent number: 6255669
    Abstract: A visible light emitting device includes a wide band gap semiconductor layer doped with one or more elements which emit light at various wavelengths based upon atomic transitions. The semiconductor preferably is GaN, InN, AIN, BN or alloys thereof doped with a lanthanide element such as Er, Pr or Tm. The light emission can be enhanced by annealing the WBGS.
    Type: Grant
    Filed: April 23, 1999
    Date of Patent: July 3, 2001
    Assignee: The University of Cincinnati
    Inventors: Ronald H. Birkhahn, Liang-Chiun Chao, Michael J. Garter, James D. Scofield, Andrew J. Steckl
  • Patent number: 6254940
    Abstract: The present invention related to methods of manufacturing oxide, nitride, carbide, and boride powders and other ceramic, organic, metallic, carbon and alloy powders and films and their mixtures having well-controlled size and crystallinity characteristics. This invention relates, more particularly, to a development in the synthesis of the ceramic, metallic, composite, carbon and alloy nanometer-sized particles with precisely controlled specific surface area, or primary particle size, crystallinity and composition. The product made using the process of the present invention and the use of that product are also claimed herein.
    Type: Grant
    Filed: May 26, 1999
    Date of Patent: July 3, 2001
    Assignee: University of Cincinnati
    Inventors: Sotiris E. Pratsinis, Srinivas Vemury
  • Patent number: 6248217
    Abstract: This invention is directed to a process for forming a sorbent-metal complex. The process includes oxidizing a sorbent precursor and contacting the sorbent precursor with a metallic species. The process further includes chemically reacting the sorbent precursor and the metallic species, thereby forming a sorbent-metal complex. In one particular aspect of the invention, at least a portion of the sorbent precursor is transformed into sorbent particles during the oxidation step. These sorbent particles then are contacted with the metallic species and chemically reacted with the metallic species, thereby forming a sorbent-metal complex. Another aspect of the invention is directed to a process for forming a sorbent metal complex in a combustion system. The process includes introducing a sorbent precursor into a combustion system and subjecting the sorbent precursor to an elevated temperature sufficient to oxidize the sorbent precursor and transform the sorbent precursor into sorbent particles.
    Type: Grant
    Filed: April 8, 1998
    Date of Patent: June 19, 2001
    Assignee: The University of Cincinnati
    Inventors: Pratim Biswas, Chang-Yu Wu